GENNEX LABORATORIES Financial Statement Analysis
|
||
|
The Revenues of GENNEX LABORATORIES have increased by 32.18% YoY .
The Earnings Per Share (EPS) of GENNEX LABORATORIES has increased by 60.00 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
GENNEX LABORATORIES Last 5 Annual Financial Results
[BOM: 531739]
| Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹87 Cr | ₹66 Cr | ₹61 Cr | ₹60 Cr | ₹56 Cr |
| Expenses | ₹70 Cr | ₹61 Cr | ₹56 Cr | ₹53 Cr | ₹52 Cr |
| Operating Profit (Excl OI) | ₹17 Cr | ₹4.69 Cr | ₹5.38 Cr | ₹6.53 Cr | ₹3.25 Cr |
| Other Income | ₹4.91 Cr | ₹3.95 Cr | ₹1.38 Cr | ₹0.52 Cr | ₹0.95 Cr |
| Interest | ₹3.08 Cr | ₹1.35 Cr | ₹0.88 Cr | ₹0.74 Cr | ₹0.75 Cr |
| Depreciation | ₹2.37 Cr | ₹0.92 Cr | ₹0.79 Cr | ₹0.88 Cr | ₹1.01 Cr |
| Profit Before Tax | ₹16 Cr | ₹6.37 Cr | ₹5.09 Cr | ₹5.06 Cr | ₹2.55 Cr |
| Profit After Tax | ₹13 Cr | ₹4.92 Cr | ₹3.92 Cr | ₹4.04 Cr | ₹1.86 Cr |
| Consolidated Net Profit | ₹11 Cr | ₹6.19 Cr | ₹4.11 Cr | ₹4.04 Cr | ₹1.86 Cr |
| Earnings Per Share (Rs) | ₹0.80 | ₹0.50 | ₹0.35 | ₹0.32 | ₹0.32 |
| PAT Margin (%) | 11.60 | 13.40 | 6.85 | 6.01 | 6.34 |
| ROE(%) | 10.49 | 10.77 | 7.95 | 9.39 | 10.71 |
| ROCE(%) | 12.49 | 13.64 | 10.19 | 11.82 | 13.24 |
| Total Debt/Equity(x) | 0.13 | 0.12 | 0.22 | 0.23 | 0.19 |
Key Financials |
||
| Market Cap | : | ₹ 364.6 Cr |
| Revenue (TTM) | : | ₹ 147.9 Cr |
| Net Profit(TTM) | : | ₹ 18.5 Cr |
| EPS (TTM) | : | ₹ 0.8 |
| P/E (TTM) | : | 19.7 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| GENNEX LABORATORIES | -4.4% | 7.8% | -23% |
| SUN PHARMACEUTICAL INDUSTRIES | 2.8% | 6.6% | -2.1% |
| DIVIS LABORATORIES | -0.2% | -0.7% | 10.5% |
| CIPLA | 1.4% | -1.4% | -1.4% |
| TORRENT PHARMACEUTICALS | -0.2% | 8.1% | 21.8% |
| DR REDDYS LABORATORIES | 2.7% | 1% | -3.4% |
| MANKIND PHARMA | 1.1% | -8.2% | -14.3% |
| ZYDUS LIFESCIENCES | -0.4% | -4.4% | -2.5% |
| LUPIN | 3.9% | 5.7% | -1.4% |
GENNEX LABORATORIES Revenues
[BOM: 531739]
| Y-o-Y | 32.18 % |
| 5 Yr CAGR | 11.74 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹87 Cr | 32.18 | |
| Mar2024 | ₹66 Cr | 7.17 | |
| Mar2023 | ₹61 Cr | 2.62 | |
| Mar2022 | ₹60 Cr | 7.25 | |
| Mar2021 | ₹56 Cr | - | |
GENNEX LABORATORIES Operating Profit
[BOM: 531739]
| Y-o-Y | 262.88 % |
| 5 Yr CAGR | 51.33 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹17 Cr | 262.88 | |
| Mar2024 | ₹4.69 Cr | -12.74 | |
| Mar2023 | ₹5.38 Cr | -17.68 | |
| Mar2022 | ₹6.53 Cr | 101.20 | |
| Mar2021 | ₹3.25 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 174.69 % |
| 5 Yr CAGR | 35.42 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 19.64% | 174.69 | |
| Mar2024 | 7.15% | -18.66 | |
| Mar2023 | 8.79% | -19.73 | |
| Mar2022 | 10.95% | 87.50 | |
| Mar2021 | 5.84% | - | |
GENNEX LABORATORIES Profit After Tax
[BOM: 531739]
| Y-o-Y | 83.61 % |
| 5 Yr CAGR | 57.33 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹11 Cr | 83.61 | |
| Mar2024 | ₹6.19 Cr | 50.89 | |
| Mar2023 | ₹4.11 Cr | 1.66 | |
| Mar2022 | ₹4.04 Cr | 117.56 | |
| Mar2021 | ₹1.86 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -13.43 % |
| 5 Yr CAGR | 16.30 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 11.6 % | -13.43 | |
| Mar2024 | 13.4 % | 95.62 | |
| Mar2023 | 6.85 % | 13.98 | |
| Mar2022 | 6.01 % | -5.21 | |
| Mar2021 | 6.34 % | - | |
GENNEX LABORATORIES Earnings Per Share (EPS)
[BOM: 531739]
| Y-o-Y | 60.00 % |
| 5 Yr CAGR | 25.74 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.80 | 60.00 | |
| Mar2024 | ₹0.50 | 42.86 | |
| Mar2023 | ₹0.35 | 9.37 | |
| Mar2022 | ₹0.32 | 0.00 | |
| Mar2021 | ₹0.32 | - | |
GENNEX LABORATORIES Return on Capital Employed (ROCE)
[BOM: 531739]
| Y-o-Y | -8.43 % |
| 5 Yr CAGR | -1.45 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 12.49% | -8.43 | |
| Mar2024 | 13.64% | 33.86 | |
| Mar2023 | 10.19% | -13.79 | |
| Mar2022 | 11.82% | -10.73 | |
| Mar2021 | 13.24% | - | |
GENNEX LABORATORIES Share Price vs Sensex
| Current Share Price | : | ₹15.0 |
| Current MarketCap | : | ₹ 364.6 Cr |
| Updated EOD on | : | Nov 17,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | -4.4% |
7.8% |
-23% |
| SENSEX | 1.7% |
3.6% |
6.9% |
GENNEX LABORATORIES related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about GENNEX LABORATORIES Financials
How the annual revenues of GENNEX LABORATORIES have changed ?
The Revenues of GENNEX LABORATORIES have increased by 32.18% YoY .
How the Earnings per Share (EPS) of GENNEX LABORATORIES have changed?
The Earnings Per Share (EPS) of GENNEX LABORATORIES has increased by 60.00 % YoY .
Check out Intrinsic Value of Peers of GENNEX LABORATORIES
Compare Stock Analytics of Peers of GENNEX LABORATORIES
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
